Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Bertalot, G; Villanacci, V; Gramegna, M; Orvieto, E; Negrini, R; Saleri, A; Terraroli, C; Ravelli, R; Cestari, R; Viale, G
   Evidence of Epstein-Barr virus infection in ulcerative colitis
   DIGESTIVE AND LIVER DISEASE
   
   G. Bertalot et al., "Evidence of Epstein-Barr virus infection in ulcerative colitis", DIG LIVER D, 33(7), 2001, pp. 551-558
2. Qasim, A; Seery, J; O'Morain, CA
   5-Aminosalicylates in inflammatory bowel disease: choosing the right dose
   DIGESTIVE AND LIVER DISEASE
   
   A. Qasim et al., "5-Aminosalicylates in inflammatory bowel disease: choosing the right dose", DIG LIVER D, 33(5), 2001, pp. 393-398
3. Triantafillidis, JK; Hyphantis, T; Driva, G; Cheracakis, P; Hereti, I; Barbatzas, C; Konstantellou, H
   Ornidazole treatment in normal subjects reduces serum levels of C3
   DIGESTIVE AND LIVER DISEASE
   
   J.K. Triantafillidis et al., "Ornidazole treatment in normal subjects reduces serum levels of C3", DIG LIVER D, 33(3), 2001, pp. 302-303
4. de Jong, YP; Abadia-Molina, AC; Satoskar, AR; Clarke, K; Rietdijk, ST; Faubion, WA; Mizoguchi, E; Metz, CN; Al Sahli, M; ten Hove, T; Keates, AC; Lubetsky, JB; Farrell, RJ; Michetti, P; van Deventer, SJ; Lolis, E; David, JR; Bhan, AK; Terhorst, C
   Development of chronic colitis is dependent on the cytokine MIF
   NATURE IMMUNOLOGY
   
   Y.P. de Jong et al., "Development of chronic colitis is dependent on the cytokine MIF", NAT IMMUNOL, 2(11), 2001, pp. 1061-1066
5. Martin, K; Heinzlmann, M; Borchers, R; Mack, M; Loeschke, K; Folwaczny, C
   Delta 32 mutation of the chemokine-receptor 5 gene in inflammatory bowel disease
   CLINICAL IMMUNOLOGY
   
   K. Martin et al., "Delta 32 mutation of the chemokine-receptor 5 gene in inflammatory bowel disease", CLIN IMMUNO, 98(1), 2001, pp. 18-22
6. Weaver, SA; Ward, SG
   Phosphoinositide 3-kinases in the gut: a link between inflammation and cancer?
   TRENDS IN MOLECULAR MEDICINE
   
   S.A. Weaver e S.G. Ward, "Phosphoinositide 3-kinases in the gut: a link between inflammation and cancer?", TRENDS MO M, 7(10), 2001, pp. 455-462
7. MacDonald, TT; Monteleone, G
   IL-12 and Th1 immune responses in human Peyer's patches
   TRENDS IN IMMUNOLOGY
   
   T.T. MacDonald e G. Monteleone, "IL-12 and Th1 immune responses in human Peyer's patches", TRENDS IMMU, 22(5), 2001, pp. 244-247
8. Neurath, MF; Finotto, S; Fuss, I; Boirivant, M; Galle, PR; Strober, W
   Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question
   TRENDS IN IMMUNOLOGY
   
   M.F. Neurath et al., "Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question", TRENDS IMMU, 22(1), 2001, pp. 21-26
9. Marriott, JB; Muller, G; Stirling, D; Dalgleish, AG
   Immunotherapeutic and antitumour potential of thalidomide analogues
   EXPERT OPINION ON BIOLOGICAL THERAPY
   
   J.B. Marriott et al., "Immunotherapeutic and antitumour potential of thalidomide analogues", EXPERT OP B, 1(4), 2001, pp. 675-682
10. Palm, O; Moum, B; Jahnsen, J; Gran, JT
    The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study)
    RHEUMATOLOGY
    
    O. Palm et al., "The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study)", RHEUMATOLOG, 40(11), 2001, pp. 1256-1261
11. Ballinger, AB; Camacho-Hubner, C; Croft, NM
    Growth failure and intestinal inflammation
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    
    A.B. Ballinger et al., "Growth failure and intestinal inflammation", QJM-MON J A, 94(3), 2001, pp. 121-125
12. Hutchins, RR; Hani, AB; Kojodjojo, P; Ho, R; Snooks, SJ
    Adenocarcinoma of the small bowel
    ANZ journal of surgery
    
    R.R. Hutchins et al., "Adenocarcinoma of the small bowel", AUST NZ J S, 71(7), 2001, pp. 428-437
13. Kern, A; Schunk, K; Kessler, M; Oberholzer, K; Thelen, M
    Hydro-MRI for abdominal diagnostics in children.
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN
    
    A. Kern et al., "Hydro-MRI for abdominal diagnostics in children.", ROFO-F RONT, 173(11), 2001, pp. 984-990
14. Hansmann, HJ; Hess, T; Hahmann, M; Erb, G; Elsing, C; Richter, GM; Dux, M
    MRI for chronic inflammatory bowel disease.
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN
    
    H.J. Hansmann et al., "MRI for chronic inflammatory bowel disease.", ROFO-F RONT, 173(1), 2001, pp. 4-11
15. Belluzzi, A
    N-3 and n-6 fatty acids for the treatment of autoimmune diseases
    EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY
    
    A. Belluzzi, "N-3 and n-6 fatty acids for the treatment of autoimmune diseases", EUR J LIPID, 103(6), 2001, pp. 399-407
16. Schuetz, A; Jauch, KT
    Lower gastrointestinal bleeding: therapeutic strategies, surgical techniques and results
    LANGENBECKS ARCHIVES OF SURGERY
    
    A. Schuetz e K.T. Jauch, "Lower gastrointestinal bleeding: therapeutic strategies, surgical techniques and results", LANG ARCH S, 386(1), 2001, pp. 17-25
17. Fujii, T; Seki, T; Maruoka, M; Tanaka, J; Kawashima, Y; Watanabe, T; Sawamura, T; Inoue, K
    Lactulose-L-rhamnose intestinal permeability test in patients with liver cirrhosis
    HEPATOLOGY RESEARCH
    
    T. Fujii et al., "Lactulose-L-rhamnose intestinal permeability test in patients with liver cirrhosis", HEPATOL RES, 19(2), 2001, pp. 158-169
18. Bondeson, J; Maini, RN
    Tumour necrosis factor as a therapeutic target in rheumatoid arthritis andother chronic inflammatory diseases: The clinical experience with infliximab (Remicade (TM))
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    J. Bondeson e R.N. Maini, "Tumour necrosis factor as a therapeutic target in rheumatoid arthritis andother chronic inflammatory diseases: The clinical experience with infliximab (Remicade (TM))", INT J CL PR, 55(3), 2001, pp. 211-216
19. Kane, SV
    Novel therapies in the treatment of ulcerative colitis
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    S.V. Kane, "Novel therapies in the treatment of ulcerative colitis", EXPERT OP I, 10(7), 2001, pp. 1223-1229
20. Gionchetti, P; Amadini, C; Rizzello, F; Venturi, A; Romagnoli, R; Palmonari, V; De Simone, C; Campieri, M
    Role of probiotics in inflammatory bowel disease and intestinal infections
    EXPERT OPINION ON THERAPEUTIC PATENTS
    
    P. Gionchetti et al., "Role of probiotics in inflammatory bowel disease and intestinal infections", EXPERT OP T, 11(8), 2001, pp. 1277-1283
21. Bernstein, CN
    Novel therapeutics in inflammatory bowel disease
    EXPERT OPINION ON THERAPEUTIC PATENTS
    
    C.N. Bernstein, "Novel therapeutics in inflammatory bowel disease", EXPERT OP T, 11(7), 2001, pp. 1081-1096
22. Moreels, TG; De Man, JG; De Winter, BY; Timmermans, JP; Herman, AG; Pelckmans, PA
    Effect of 2,4,6-trinitrobenzenesulphonic acid (TNBS)-induced ileitis on the motor function of non-inflamed rat gastric fundus
    NEUROGASTROENTEROLOGY AND MOTILITY
    
    T.G. Moreels et al., "Effect of 2,4,6-trinitrobenzenesulphonic acid (TNBS)-induced ileitis on the motor function of non-inflamed rat gastric fundus", NEUROG MOT, 13(4), 2001, pp. 339-352
23. Depoortere, I; Van Assche, G; Peeters, TL
    Motilin receptor density in inflamed and noninflamed tissue in rabbit TNBS-induced colitis
    NEUROGASTROENTEROLOGY AND MOTILITY
    
    I. Depoortere et al., "Motilin receptor density in inflamed and noninflamed tissue in rabbit TNBS-induced colitis", NEUROG MOT, 13(1), 2001, pp. 55-63
24. Steidler, L
    Microbiological and immunological strategies for treatment of inflammatorybowel disease
    MICROBES AND INFECTION
    
    L. Steidler, "Microbiological and immunological strategies for treatment of inflammatorybowel disease", MICROBES IN, 3(13), 2001, pp. 1157-1166
25. Ishaq, S; Green, JRB
    Tolerability of aminosalicylates in inflammatory bowel disease
    BIODRUGS
    
    S. Ishaq e J.R.B. Green, "Tolerability of aminosalicylates in inflammatory bowel disease", BIODRUGS, 15(5), 2001, pp. 339-349
26. Richard-Miceli, C; Dougados, M
    Tumour necrosis factor-alpha blockers in rheumatoid arthritis - Review of the clinical experience
    BIODRUGS
    
    C. Richard-Miceli e M. Dougados, "Tumour necrosis factor-alpha blockers in rheumatoid arthritis - Review of the clinical experience", BIODRUGS, 15(4), 2001, pp. 251-259
27. Meierhofer, C; Dunzendorfer, S; Wiedermann, CJ
    Theoretical basis for the activity of thalidomide
    BIODRUGS
    
    C. Meierhofer et al., "Theoretical basis for the activity of thalidomide", BIODRUGS, 15(10), 2001, pp. 681-703
28. Vree, TB; Dammers, E; Exler, PS; Maes, RAA
    Multiple absorption patterns of mesalazine from two gastroresistant tablets in healthy male volunteers - Effects of food and formulation
    CLINICAL DRUG INVESTIGATION
    
    T.B. Vree et al., "Multiple absorption patterns of mesalazine from two gastroresistant tablets in healthy male volunteers - Effects of food and formulation", CLIN DRUG I, 21(4), 2001, pp. 295-305
29. Vree, TB; Dammers, E; Exler, PS; Sorgel, F; Bondesen, S; Maes, RAA
    Upper and lower limits in the renal clearance of acetylmesalazine in humans - Indications for renal acetylation of mesalazine
    CLINICAL DRUG INVESTIGATION
    
    T.B. Vree et al., "Upper and lower limits in the renal clearance of acetylmesalazine in humans - Indications for renal acetylation of mesalazine", CLIN DRUG I, 21(2), 2001, pp. 147-156
30. Blanchard, HS; Dernis-Labous, E; Lamarque, D; van Nhieu, JT; Szepes, Z; Flejou, JF; Wollman, E; Whittle, BJR; Breban, M
    Inducible nitric oxide synthase attenuates chronic colitis in HLA-B27/human beta 2-microglobulin transgenic rats
    EUROPEAN CYTOKINE NETWORK
    
    H.S. Blanchard et al., "Inducible nitric oxide synthase attenuates chronic colitis in HLA-B27/human beta 2-microglobulin transgenic rats", EUR CYTOKIN, 12(1), 2001, pp. 111-118
31. Ramos, DL; Gabriel, R; Perona, JC; Otero, RM; Bermejo, MF; Jimenez, JM
    Association of MALTectomy (appendectomy and tonsillectomy) and inflammatory bowel disease: a familial case-control study
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
    
    D.L. Ramos et al., "Association of MALTectomy (appendectomy and tonsillectomy) and inflammatory bowel disease: a familial case-control study", REV ESP E D, 93(5), 2001, pp. 309-314
32. Lara, VG; Calle, JLP
    Epidemiology of inflammatory bowel disease in Spain
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
    
    V.G. Lara e J.L.P. Calle, "Epidemiology of inflammatory bowel disease in Spain", REV ESP E D, 93(1), 2001, pp. 5-8
33. Pajares, JM; Gisbert, JP
    Epidemiology of inflammatory bowel disease in Spain. A systematic review
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
    
    J.M. Pajares e J.P. Gisbert, "Epidemiology of inflammatory bowel disease in Spain. A systematic review", REV ESP E D, 93(1), 2001, pp. 15-20
34. Baughman, RP; Lower, EE
    Infliximab for refractory sarcoidosis
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES
    
    R.P. Baughman e E.E. Lower, "Infliximab for refractory sarcoidosis", SARCO VASC, 18(1), 2001, pp. 70-74
35. Periti, P; Tonelli, F
    Preclinical and clinical pharmacology of biotherapeutic agents: Saccharomyces boulardii
    JOURNAL OF CHEMOTHERAPY
    
    P. Periti e F. Tonelli, "Preclinical and clinical pharmacology of biotherapeutic agents: Saccharomyces boulardii", J CHEMOTHER, 13(5), 2001, pp. 473-493
36. Kamm, MA
    New therapeutic possibilities in inflammatory bowel disease
    EUROPEAN JOURNAL OF SURGERY
    
    M.A. Kamm, "New therapeutic possibilities in inflammatory bowel disease", EURO J SURG, 167, 2001, pp. 30-33
37. Rutgeerts, P; Geboes, K
    Understanding inflammatory bowel disease - The clinician's perspective
    EUROPEAN JOURNAL OF SURGERY
    
    P. Rutgeerts e K. Geboes, "Understanding inflammatory bowel disease - The clinician's perspective", EURO J SURG, 167, 2001, pp. 66-72
38. Andersson, P; Sjodahl, R
    Controversies in surgical treatment of inflammatory bowel disease
    EUROPEAN JOURNAL OF SURGERY
    
    P. Andersson e R. Sjodahl, "Controversies in surgical treatment of inflammatory bowel disease", EURO J SURG, 167, 2001, pp. 73-77
39. Yang, HY; Taylor, KD; Rotter, JI
    Inflammatory bowel disease - I. Genetic epidemiology
    MOLECULAR GENETICS AND METABOLISM
    
    H.Y. Yang et al., "Inflammatory bowel disease - I. Genetic epidemiology", MOL GEN MET, 74(1-2), 2001, pp. 1-21
40. Ko, JKS; Sham, NF; Guo, X; Cho, CH
    Beneficial intervention of experimental colitis by passive cigarette smoking through the modulation of cytokines in rats
    JOURNAL OF INVESTIGATIVE MEDICINE
    
    J.K.S. Ko et al., "Beneficial intervention of experimental colitis by passive cigarette smoking through the modulation of cytokines in rats", J INVES MED, 49(1), 2001, pp. 21-29
41. Gan, XD; Wong, BM; Wright, SD; Cai, TQ
    Production of matrix metalloproteinase-9 in CaCO-2 cells in response to inflammatory stimuli
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    
    X.D. Gan et al., "Production of matrix metalloproteinase-9 in CaCO-2 cells in response to inflammatory stimuli", J INTERF CY, 21(2), 2001, pp. 93-98
42. Wester, AL; Vatn, MH; Fausa, O
    Secondary amyloidosis in inflammatory bowel disease: A study of 18 patients admitted to Rikshospitalet University Hospital, Oslo, from 1962 to 1998
    INFLAMMATORY BOWEL DISEASES
    
    A.L. Wester et al., "Secondary amyloidosis in inflammatory bowel disease: A study of 18 patients admitted to Rikshospitalet University Hospital, Oslo, from 1962 to 1998", INFLAMM B D, 7(4), 2001, pp. 295-300
43. Kempton, CL; Bagby, G; Collins, JF
    Ulcerative colitis presenting as purpura fulminans
    INFLAMMATORY BOWEL DISEASES
    
    C.L. Kempton et al., "Ulcerative colitis presenting as purpura fulminans", INFLAMM B D, 7(4), 2001, pp. 319-322
44. Baert, F; Rutgeerts, P
    6-Thioguanine: A naked bullet? (or how pharmacogenomics can make old drugsbrand new)
    INFLAMMATORY BOWEL DISEASES
    
    F. Baert e P. Rutgeerts, "6-Thioguanine: A naked bullet? (or how pharmacogenomics can make old drugsbrand new)", INFLAMM B D, 7(3), 2001, pp. 190-191
45. Omata, F; Birkenbach, M; Matsuzaki, S; Christ, AD; Blumberg, RS
    The expression of IL-12 p40 and its homologue Epstien-Barr virus-induced gene 3, in inflammatory bowel disease
    INFLAMMATORY BOWEL DISEASES
    
    F. Omata et al., "The expression of IL-12 p40 and its homologue Epstien-Barr virus-induced gene 3, in inflammatory bowel disease", INFLAMM B D, 7(3), 2001, pp. 215-220
46. Lawrance, IC; Maxwell, L; Doe, W
    Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease
    INFLAMMATORY BOWEL DISEASES
    
    I.C. Lawrance et al., "Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease", INFLAMM B D, 7(3), 2001, pp. 226-236
47. Cucino, C; Sonnenberg, A
    Cause of death in patients with inflammatory bowel disease
    INFLAMMATORY BOWEL DISEASES
    
    C. Cucino e A. Sonnenberg, "Cause of death in patients with inflammatory bowel disease", INFLAMM B D, 7(3), 2001, pp. 250-255
48. Yang, SK; Loftus, EV; Sandborn, WJ
    Epidemiology of inflammatory bowel disease in Asia
    INFLAMMATORY BOWEL DISEASES
    
    S.K. Yang et al., "Epidemiology of inflammatory bowel disease in Asia", INFLAMM B D, 7(3), 2001, pp. 260-270
49. Sands, BE; Tremaine, WJ; Sandborn, WJ; Rutgeerts, PJ; Hanauer, SB; Mayer, L; Targan, SR; Podolsky, DK
    Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: A pilot study
    INFLAMMATORY BOWEL DISEASES
    
    B.E. Sands et al., "Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: A pilot study", INFLAMM B D, 7(2), 2001, pp. 83-88
50. Lichtenstein, GR
    Is infliximab effective for induction of remission in patients with ulcerative colitis?
    INFLAMMATORY BOWEL DISEASES
    
    G.R. Lichtenstein, "Is infliximab effective for induction of remission in patients with ulcerative colitis?", INFLAMM B D, 7(2), 2001, pp. 89-93
51. Vento, P; Kiviluoto, T; Jarvinen, HJ; Karkkainen, P; Kivilaakso, E; Soinila, S
    Expression of inducible and endothelial nitric oxide synthases in pouchitis
    INFLAMMATORY BOWEL DISEASES
    
    P. Vento et al., "Expression of inducible and endothelial nitric oxide synthases in pouchitis", INFLAMM B D, 7(2), 2001, pp. 120-127
52. Haslam, N; Standen, GR; Probert, CS
    An investigation of the association of the prothrombin G20210A gene mutation and inflammatory bowel disease: Factor II and IBD
    INFLAMMATORY BOWEL DISEASES
    
    N. Haslam et al., "An investigation of the association of the prothrombin G20210A gene mutation and inflammatory bowel disease: Factor II and IBD", INFLAMM B D, 7(2), 2001, pp. 133-135
53. Dunne, C
    Adaptation of bacteria to the intestinal niche: Probiotics and gut disorder
    INFLAMMATORY BOWEL DISEASES
    
    C. Dunne, "Adaptation of bacteria to the intestinal niche: Probiotics and gut disorder", INFLAMM B D, 7(2), 2001, pp. 136-145
54. Katz, JA; Pore, G
    Inflammatory bowel disease and pregnancy
    INFLAMMATORY BOWEL DISEASES
    
    J.A. Katz e G. Pore, "Inflammatory bowel disease and pregnancy", INFLAMM B D, 7(2), 2001, pp. 146-157
55. Papaioannou, A; Ferko, NC; Adachi, JD
    All patients with inflammatory bowel disease should have bone density assessment: Pro
    INFLAMMATORY BOWEL DISEASES
    
    A. Papaioannou et al., "All patients with inflammatory bowel disease should have bone density assessment: Pro", INFLAMM B D, 7(2), 2001, pp. 158-162
56. Leslie, WD
    All patients with inflammatory bowel disease should have bone density assessment: Con
    INFLAMMATORY BOWEL DISEASES
    
    W.D. Leslie, "All patients with inflammatory bowel disease should have bone density assessment: Con", INFLAMM B D, 7(2), 2001, pp. 163-167
57. Bernstein, CN
    All patients with inflammatory bowel disease should have bone density assessment
    INFLAMMATORY BOWEL DISEASES
    
    C.N. Bernstein, "All patients with inflammatory bowel disease should have bone density assessment", INFLAMM B D, 7(2), 2001, pp. 168-169
58. Friedman, S; Marion, JF; Scherl, E; Rubin, PH; Present, DH
    Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease
    INFLAMMATORY BOWEL DISEASES
    
    S. Friedman et al., "Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease", INFLAMM B D, 7(1), 2001, pp. 1-7
59. Vermeire, S; Peeters, M; Vlietinck, R; Joossens, S; Den Hond, E; Bulteel, V; Bossuyt, X; Geypens, B; Rutgeerts, P
    Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: A study in IBD families
    INFLAMMATORY BOWEL DISEASES
    
    S. Vermeire et al., "Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: A study in IBD families", INFLAMM B D, 7(1), 2001, pp. 8-15
60. Lawrance, IC; Maxwell, L; Doe, W
    Inflammation location, but not type, determines the increase in TGF-beta 1and IGF-1 expression and collagen deposition in IBD intestine
    INFLAMMATORY BOWEL DISEASES
    
    I.C. Lawrance et al., "Inflammation location, but not type, determines the increase in TGF-beta 1and IGF-1 expression and collagen deposition in IBD intestine", INFLAMM B D, 7(1), 2001, pp. 16-26
61. Sutherland, LR
    Budesonide: Is no evidence of a difference the same as evidence of no difference?
    INFLAMMATORY BOWEL DISEASES
    
    L.R. Sutherland, "Budesonide: Is no evidence of a difference the same as evidence of no difference?", INFLAMM B D, 7(1), 2001, pp. 58-59
62. Janowitz, HD; Bodian, C
    The placebo response and the "natural history" of inflammatory bowel disease
    INFLAMMATORY BOWEL DISEASES
    
    H.D. Janowitz e C. Bodian, "The placebo response and the "natural history" of inflammatory bowel disease", INFLAMM B D, 7(1), 2001, pp. 64-66
63. Sandborn, WJ
    Transcending conventional therapies: The role of biologic and other novel therapies
    INFLAMMATORY BOWEL DISEASES
    
    W.J. Sandborn, "Transcending conventional therapies: The role of biologic and other novel therapies", INFLAMM B D, 7, 2001, pp. S9-S16
64. Chey, WY
    Infliximab for patients with refractory ulcerative colitis
    INFLAMMATORY BOWEL DISEASES
    
    W.Y. Chey, "Infliximab for patients with refractory ulcerative colitis", INFLAMM B D, 7, 2001, pp. S30-S33
65. Laroux, FS; Grisham, MB
    Immunological basis of inflammatory bowel disease: Role of the microcirculation
    MICROCIRCULATION
    
    F.S. Laroux e M.B. Grisham, "Immunological basis of inflammatory bowel disease: Role of the microcirculation", MICROCIRCUL, 8(5), 2001, pp. 283-301
66. Sharp, KW
    What's new in general surgery: Gastrointestinal conditions
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
    
    K.W. Sharp, "What's new in general surgery: Gastrointestinal conditions", J AM COLL S, 193(5), 2001, pp. 516-525
67. Davis, RL; Kramarz, P; Bohlke, K; Benson, P; Thompson, RS; Mullooly, J; Black, S; Shinefield, H; Lewis, E; Ward, J; Marcy, SM; Eriksen, E; Destefano, F; Chen, R
    Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease - A case-control study from the Vaccine Safety Datalink Project
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
    
    R.L. Davis et al., "Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease - A case-control study from the Vaccine Safety Datalink Project", ARCH PED AD, 155(3), 2001, pp. 354-359
68. Serrano, MS; Schmidt-Sommerfeld, E; Kilbaugh, TJ; Brown, RF; Udall, JN; Mannick, EE
    Use of infliximab in pediatric patients with inflammatory bowel disease
    ANNALS OF PHARMACOTHERAPY
    
    M.S. Serrano et al., "Use of infliximab in pediatric patients with inflammatory bowel disease", ANN PHARMAC, 35(7-8), 2001, pp. 823-828
69. Hungermann, D; Muller, S; Spieker, T; Lisner, R; Niedobitek, G; Herbst, H
    Low prevalence of latently Epstein-Barr virus-infected cells in chronic gastritis
    MICROSCOPY RESEARCH AND TECHNIQUE
    
    D. Hungermann et al., "Low prevalence of latently Epstein-Barr virus-infected cells in chronic gastritis", MICROSC RES, 53(6), 2001, pp. 409-413
70. Sylvester, FA
    An update on bone abnormalities associated with gastrointestinal and liverdisease
    ENDOCRINOLOGIST
    
    F.A. Sylvester, "An update on bone abnormalities associated with gastrointestinal and liverdisease", ENDOCRINOLO, 11(2), 2001, pp. 77
71. Shao, L; Serrano, D; Mayer, L
    The role of epithelial cells in immune regulation in the gut
    SEMINARS IN IMMUNOLOGY
    
    L. Shao et al., "The role of epithelial cells in immune regulation in the gut", SEMIN IMMUN, 13(3), 2001, pp. 163-175
72. Levine, AD; Fiocchi, C
    Regulation of life and death in lamina propria T cells
    SEMINARS IN IMMUNOLOGY
    
    A.D. Levine e C. Fiocchi, "Regulation of life and death in lamina propria T cells", SEMIN IMMUN, 13(3), 2001, pp. 195-199
73. Novick, D; Schwartsburd, B; Pinkus, R; Suissa, D; Belzer, I; Sthoeger, Z; Keane, WF; Chvatchko, Y; Kim, SH; Fantuzzi, G; Dinarello, CA; Rubinstein, M
    A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensivedecrease of free IL-18
    CYTOKINE
    
    D. Novick et al., "A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensivedecrease of free IL-18", CYTOKINE, 14(6), 2001, pp. 334-342
74. Lo, HC; Tsai, FA; Lin, SC; Wang, HF
    Systemic and local secretions of cytokines and nitric oxide in massive bowel resected rats with or without small bowel segment reversal
    CYTOKINE
    
    H.C. Lo et al., "Systemic and local secretions of cytokines and nitric oxide in massive bowel resected rats with or without small bowel segment reversal", CYTOKINE, 14(2), 2001, pp. 112-120
75. Coeffier, M; Miralles-Barrachina, O; Le Pessot, F; Lalaude, O; Daveau, M; Lavoinne, A; Lerebours, E; Dechelotte, P
    Influence of glutamine on cytokine production by human gut in vitro
    CYTOKINE
    
    M. Coeffier et al., "Influence of glutamine on cytokine production by human gut in vitro", CYTOKINE, 13(3), 2001, pp. 148-154
76. Vincenzi, B; Finolezzi, E; Fossati, C; Verzi, A; Santini, D; Tonini, G; Arullani, A; Avvisati, G
    Unusual presentation of Hodgkin's disease mimicking inflammatory bowel disease
    LEUKEMIA & LYMPHOMA
    
    B. Vincenzi et al., "Unusual presentation of Hodgkin's disease mimicking inflammatory bowel disease", LEUK LYMPH, 42(3), 2001, pp. 521-526
77. Hohler, T; Marker-Hermann, E
    Psoriatic arthritis: clinical aspects, genetics, and the role of T cells
    CURRENT OPINION IN RHEUMATOLOGY
    
    T. Hohler e E. Marker-Hermann, "Psoriatic arthritis: clinical aspects, genetics, and the role of T cells", CURR OP RH, 13(4), 2001, pp. 273-279
78. Wollheim, FA
    Enteropathic arthritis: how do the joints talk with the gut?
    CURRENT OPINION IN RHEUMATOLOGY
    
    F.A. Wollheim, "Enteropathic arthritis: how do the joints talk with the gut?", CURR OP RH, 13(4), 2001, pp. 305-309
79. Hyams, JS
    Gastroenterology and nutrition
    CURRENT OPINION IN PEDIATRICS
    
    J.S. Hyams, "Gastroenterology and nutrition", CURR OP PED, 13(5), 2001, pp. 423-424
80. Farrell, RJ; Banerjee, S; Peppercorn, MA
    Recent advances in inflammatory bowel disease
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
    
    R.J. Farrell et al., "Recent advances in inflammatory bowel disease", CR R CL LAB, 38(1), 2001, pp. 33-108
81. Bruwer, M; Schmid, KW; Metz, KA; Krieglstein, CF; Senninger, N; Schurmann, G
    Increased expression of metallothionein in inflammatory bowel disease
    INFLAMMATION RESEARCH
    
    M. Bruwer et al., "Increased expression of metallothionein in inflammatory bowel disease", INFLAMM RES, 50(6), 2001, pp. 289-293
82. McCormack, G; Moriarty, D; O'Donoghue, DP; McCormick, PA; Sheahan, K; Baird, AW
    Tissue cytokine and chemokine expression in inflammatory bowel disease
    INFLAMMATION RESEARCH
    
    G. McCormack et al., "Tissue cytokine and chemokine expression in inflammatory bowel disease", INFLAMM RES, 50(10), 2001, pp. 491-495
83. Kupka, S; Schroder, K; Porschen, R; Borchard, F; Gregor, M; Blin, N; Holzmann, K
    Comparative genomic hybridization analysis of chromosomal alterations in patients with long-standing ulcerative colitis
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    S. Kupka et al., "Comparative genomic hybridization analysis of chromosomal alterations in patients with long-standing ulcerative colitis", INT J ONCOL, 19(3), 2001, pp. 489-494
84. Dechairo, B; Dimon, C; van Heel, D; Mackay, I; Edwards, M; Scambler, P; Jewell, D; Cardon, L; Lench, N; Carey, A
    Replication and extension studies of inflammatory bowel disease susceptibility regions confirm linkage to chromosome 6p (IBD3)
    EUROPEAN JOURNAL OF HUMAN GENETICS
    
    B. Dechairo et al., "Replication and extension studies of inflammatory bowel disease susceptibility regions confirm linkage to chromosome 6p (IBD3)", EUR J HUM G, 9(8), 2001, pp. 627-633
85. Paavola, P; Helio, T; Kiuru, M; Halme, L; Turunen, U; Terwilliger, J; Karvonen, AL; Julkunen, R; Niemela, S; Nurmi, H; Farkkila, M; Kontula, K
    Genetic analysis in Finnish families with inflammatory bowel disease supports linkage to chromosome 3p21
    EUROPEAN JOURNAL OF HUMAN GENETICS
    
    P. Paavola et al., "Genetic analysis in Finnish families with inflammatory bowel disease supports linkage to chromosome 3p21", EUR J HUM G, 9(5), 2001, pp. 328-334
86. Zouali, H; Chamaillard, M; Lesage, S; Cezard, JP; Colombel, JF; Belaiche, J; Almer, S; Tysk, C; Montague, S; Gassull, M; Christensen, S; Finkel, Y; Gower-Rousseau, C; Modigliani, R; Macry, J; Selinger-Leneman, H; Thomas, G; Hugot, JP
    Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel disease
    EUROPEAN JOURNAL OF HUMAN GENETICS
    
    H. Zouali et al., "Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel disease", EUR J HUM G, 9(10), 2001, pp. 731-742
87. Alstead, E
    Fertility and pregnancy in inflammatory bowel disease
    WORLD JOURNAL OF GASTROENTEROLOGY
    
    E. Alstead, "Fertility and pregnancy in inflammatory bowel disease", WORLD J GAS, 7(4), 2001, pp. 455-459
88. Tibbe, JA; Bjarnason, I
    Non-invasive investigation of inflammatory bowel disease
    WORLD JOURNAL OF GASTROENTEROLOGY
    
    J.A. Tibbe e I. Bjarnason, "Non-invasive investigation of inflammatory bowel disease", WORLD J GAS, 7(4), 2001, pp. 460-465
89. Goggins, MG; Shah, SA; Goh, J; Cherukuri, A; Weir, DG; Kelleher, D; Mahmud, N
    Increased urinary nitrite, a marker of nitric oxide, in active inflammatory bowel disease
    MEDIATORS OF INFLAMMATION
    
    M.G. Goggins et al., "Increased urinary nitrite, a marker of nitric oxide, in active inflammatory bowel disease", MEDIAT INFL, 10(2), 2001, pp. 69-73
90. Smolen, DM; Topp, R
    Self-care agency and quality of life among adults diagnosed with inflammatory bowel disease
    QUALITY OF LIFE RESEARCH
    
    D.M. Smolen e R. Topp, "Self-care agency and quality of life among adults diagnosed with inflammatory bowel disease", QUAL LIFE R, 10(4), 2001, pp. 379-387
91. Hermon-Taylor, J
    Mycobacterium avium subspecies paratuberculosis: the nature of the problem
    FOOD CONTROL
    
    J. Hermon-Taylor, "Mycobacterium avium subspecies paratuberculosis: the nature of the problem", FOOD CONTRO, 12(6), 2001, pp. 331-334
92. Teitelbaum, JE; Walker, WA
    Review: the role of omega 3 fatty acids in intestinal inflammation
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY
    
    J.E. Teitelbaum e W.A. Walker, "Review: the role of omega 3 fatty acids in intestinal inflammation", J NUTR BIOC, 12(1), 2001, pp. 21-32
93. Campbell, S; Ghosh, S
    Is neutropenia required for effective maintenance of remission during azathioprine therapy in inflammatory bowel disease?
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    S. Campbell e S. Ghosh, "Is neutropenia required for effective maintenance of remission during azathioprine therapy in inflammatory bowel disease?", EUR J GASTR, 13(9), 2001, pp. 1073-1076
94. Astegiano, M; Bresso, F; Cammarota, T; Sarno, A; Robotti, D; Demarchi, B; Sostegni, R; Macchiarella, V; Pera, A; Rizzetto, M
    Abdominal pain and bowel dysfunction: diagnostic role of intestinal ultrasound
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    M. Astegiano et al., "Abdominal pain and bowel dysfunction: diagnostic role of intestinal ultrasound", EUR J GASTR, 13(8), 2001, pp. 927-931
95. Ikeda, Y; Akbar, F; Matsui, H; Onji, M
    Characterization of antigen-presenting dendritic cells in the peripheral blood and colonic mucosa of patients with ulcerative colitis
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    Y. Ikeda et al., "Characterization of antigen-presenting dendritic cells in the peripheral blood and colonic mucosa of patients with ulcerative colitis", EUR J GASTR, 13(7), 2001, pp. 841-850
96. Zeeh, JM; Riley, NE; Hoffmann, P; Reinshagen, M; Goebell, H; Gerken, G
    Expression of insulin-like growth factor binding proteins and collagen in experimental colitis in rats
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    J.M. Zeeh et al., "Expression of insulin-like growth factor binding proteins and collagen in experimental colitis in rats", EUR J GASTR, 13(7), 2001, pp. 851-858
97. Casellas, F; Lopez-Vivancos, J; Badia, X; Vilaseca, J; Malagelada, JR
    Influence of inflammatory bowel disease on different dimensions of qualityof life
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    F. Casellas et al., "Influence of inflammatory bowel disease on different dimensions of qualityof life", EUR J GASTR, 13(5), 2001, pp. 567-572
98. Bouin, M; Delvaux, M; Blanc, C; Lagier, E; Delisle, MB; Fioramonti, J; Bueno, L; Frexinos, J
    Intrarectal injection of glycerol induces hypersensitivity to rectal distension in healthy subjects without modifying rectal compliance
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    M. Bouin et al., "Intrarectal injection of glycerol induces hypersensitivity to rectal distension in healthy subjects without modifying rectal compliance", EUR J GASTR, 13(5), 2001, pp. 573-580
99. Michell, NP; Lalor, P; Langman, MJS
    Heparin therapy for ulcerative colitis? Effects and mechanisms
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    N.P. Michell et al., "Heparin therapy for ulcerative colitis? Effects and mechanisms", EUR J GASTR, 13(4), 2001, pp. 449-456
100. Campbell, S; Ghosh, S
     Effective maintenance of inflammatory bowel disease remission by azathioprine does not require concurrent 5-aminosalicylate therapy
     EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
     
     S. Campbell e S. Ghosh, "Effective maintenance of inflammatory bowel disease remission by azathioprine does not require concurrent 5-aminosalicylate therapy", EUR J GASTR, 13(11), 2001, pp. 1297-1301